TRINITY BIOTECH PLCTRIBEarnings & Financial Report
Nasdaq
TRIB Q2 2024 Key Financial Metrics
营收
$30.5M
毛利润
$11.3M
营业利润
$-7.1M
净利润
$-10.1M
毛利率
36.8%
营业利润率
-23.2%
净利率
-33.0%
同比增长
N/A
资金流向
TRINITY BIOTECH PLC Q2 2024 Financial Summary
TRINITY BIOTECH PLC reported revenue of $30.5M for Q2 2024, with a net profit of $-10.1M (-33.0% margin). Cost of goods sold was $19.3M, operating expenses totaled $18.3M.
Key Financial Metrics
| Total Revenue | $30.5M |
|---|---|
| Net Profit | $-10.1M |
| Gross Margin | 36.8% |
| Operating Margin | -23.2% |
| Report Period | Q2 2024 |
利润表
| Q2 2024 | |
|---|---|
| 营收 | $30.5M |
| 同比增长 | N/A |
资产负债表
| Q2 2024 | |
|---|---|
| 总资产 | $94.4M |
| 总负债 | $123.8M |
| 股东权益 | $-29.4M |
现金流量表
| Q2 2024 | |
|---|---|
| 经营性现金流 | $-3.9M |